These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25912617)

  • 21. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal influenza vaccination and technologies.
    Nafziger AN; Pratt DS
    J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.
    Nicoll A; Ammon A; Amato Gauci A; Ciancio B; Zucs P; Devaux I; Plata F; Mazick A; Mølbak K; Asikainen T; Kramarz P
    Public Health; 2010 Jan; 124(1):14-23. PubMed ID: 20141821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.
    Heikkinen T; Ikonen N; Ziegler T
    Clin Infect Dis; 2014 Dec; 59(11):1519-24. PubMed ID: 25139969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness.
    Ansaldi F; De Florentiis D; Parodi V; Rappazzo E; Coppelli M; Martini M; Alicino C; Durando P; Icardi G
    J Prev Med Hyg; 2012 Jun; 53(2):94-7. PubMed ID: 23240167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 32. Influenza vaccination coverage rate in children: reasons for a failure and how to go forward.
    Olivier CW
    Hum Vaccin Immunother; 2012 Jan; 8(1):107-18. PubMed ID: 22252000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
    Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
    Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic novel 2009 H1N1 influenza: what have we learned?
    LaRussa P
    Semin Respir Crit Care Med; 2011 Aug; 32(4):393-9. PubMed ID: 21858744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT).
    Cox NJ; Trock SC; Burke SA
    Curr Top Microbiol Immunol; 2014; 385():119-36. PubMed ID: 25085014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems.
    Brammer L; Budd A; Cox N
    Influenza Other Respir Viruses; 2009 Mar; 3(2):51-8. PubMed ID: 19496841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza and the work of the World Health Organization.
    Kitler ME; Gavinio P; Lavanchy D
    Vaccine; 2002 May; 20 Suppl 2():S5-14. PubMed ID: 12110248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.